News

Sinus Dynamics has discovered a treatment for Nasal Allergies, Sinus Infections and Sinusitis by combining antibiotic and anti-inflammatory medications. The company said that it offers combined antibiotic and

Alnylam has advanced the RNAi therapeutic collaboration stage of its alliance with Roche formed in 2007. In this phase of the collaboration, the partners are expected to jointly

ProChon Biotech has selected Lonza’s Hopkinton facility to manufacture its proprietary fibroblast growth factor (FGF2v) variant in the US. FGF2v is a key regulator of cellular processes involved

Medidata Solutions has extended its multi-year contract with Shire for use of Medidata Grants Manager and CRO Contractor benchmarking and analysis tools for investigator site and contract research

The company claims that the SQiDworks Diagnostics Platform and its IgXPLEX RA assay provide clinical laboratories with the ability to simultaneously measure multiple biomarkers in a single test

Mayo Clinic Proceedings has published data from a pivotal phase III trial, which demonstrated that Nuvigil (armodafinil) Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with

Dow Chemical Company has moved Geoffery Merszei, executive vice president and chief financial officer, to a new role as president of Dow Europe, Middle East and Africa. He

Novartis reported that it will invest $1billion over the next five years, increasing R&D activities in China. The company’s investment will include a significant expansion of The Novartis

Trevena has been awarded a $7.65m Grand Opportunity (GO) Grant by the office of the director of the National Institutes of Health (NIH). The grant will further fund